Anavex Life Sciences Corp (AVXL)

[kevindenver]

Waiting until facts are known before transitioning from a CRO based model to an "in-house" model was smart and frugal use of resources.

Idk but it seems as though if we don’t get approved for Alz than Missling really screwed the pooch and wasted a lot of time at the expense of shareholder value.

Traditional baby biotechs blow through all their cash on the front end pretending their results will be good. The Anavex CEO waited until facts were known before he spent the money. More examples of how very different $AVXL has grown versus traditional Wall Street roadshow funded, all style no substance biotechs.